Re: Randomized Trial of Hypofractionated, Dose-Escalated, Intensity-Modulated Radiation Therapy (IMRT) versus Conventionally Fractionated IMRT for Localized Prostate Cancer

被引：1
|
作者：
Taneja, Samir S.
机构：
来源：
JOURNAL OF UROLOGY | 2019年 / 201卷 / 05期
关键词：
D O I：
10.1097/JU.0000000000000169
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：859 / 859
页数：1
相关论文
共 50 条
  • [1] Randomized Trial of Hypofractionated, Dose-Escalated, Intensity-Modulated Radiation Therapy (IMRT) Versus Conventionally Fractionated IMRT for Localized Prostate Cancer
    Hoffman, Karen E.
    Voong, K. Ranh
    Levy, Lawrence B.
    Allen, Pamela K.
    Choi, Seungtaek
    Schlembach, Pamela J.
    Lee, Andrew K.
    McGuire, Sean E.
    Quynh Nguyen
    Pugh, Thomas J.
    Frank, Steven J.
    Kudchadker, Rajat J.
    Du, Weiliang
    Kuban, Deborah A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (29) : 2943 - +
  • [2] Randomized Trial of Hypofractionated Dose-Escalated Intensity Modulated Radiation Therapy Versus Conventionally Fractionated Intensity Modulated Radiation Therapy for Localized Prostate Cancer
    Hoffman, K. E.
    Voong, K. R.
    Levy, L. B.
    Pugh, T. J.
    Choi, S.
    Du, W.
    Frank, S. J.
    Johnson, J. L.
    Kudchadker, R.
    Nguyen, Q. N.
    Lee, A.
    Mahmood, U.
    McGuire, S. E.
    Kuban, D. A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S32 - S32
  • [3] Long-Term Outcome of Dose Escalated Hypofractionated Intensity Modulated Radiation Therapy (IMRT) for Localized Prostate Cancer
    Huang, R. Y.
    Vesprini, D.
    Bayley, A. J.
    Bristow, R. G.
    Chung, P.
    Gospodarowicz, M. K.
    Menard, C.
    Milosevic, M.
    Warde, P. R.
    Catton, C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S421 - S422
  • [4] Hypofractionated Radiation Therapy to the Prostate Bed With Intensity-Modulated Radiation Therapy (IMRT): A Phase 2 Trial
    Teixeira Leite, Elton Trigo
    Angotti Ramos, Clarissa Cerchi
    Bertotti Ribeiro, Victor Augusto
    Salvajoli, Bernardo Peres
    Nahas, William Carlos
    Salvajoli, Joao Victor
    Moraes, Fabio Ynoe
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 109 (05): : 1263 - 1270
  • [5] Dose-escalated Hypofractionated IMRT in Localised Prostate Cancer: Toxicity and Outcome
    Thomson, D.
    Merrick, S.
    Swindell, R.
    Wylie, J.
    Cowan, R.
    Elliott, T.
    Logue, J.
    Livsey, J.
    Choudhury, A.
    [J]. CLINICAL ONCOLOGY, 2011, 23 (03) : S56 - S56
  • [6] Prediction of the benefits from dose-escalated hypofractionated intensity-modulated radiotherapy for prostate cancer
    Amer, AM
    Mott, J
    Mackay, RI
    Williams, PC
    Livsey, J
    Logue, JP
    Hendry, JH
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (01): : 199 - 207
  • [7] Initial results of the intensity-modulated radiation therapy for localized and locally advanced prostate cancer (IMRT)
    Kim, Youngjoo
    [J]. BJU INTERNATIONAL, 2015, 116 : 5 - 5
  • [8] Dose-escalated intensity-modulated radiotherapy (IMRT) using a simultaneous integrated boost (SIB) in rectal cancer
    Owens, R.
    Mukherjee, S.
    Padmanaban, S.
    Hawes, E.
    Jacobs, C.
    Weaver, A.
    Betts, M.
    Muirhead, R.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 : 44 - 44
  • [9] Hypofractionated Intensity Modulated Radiation Therapy for Localized Prostate Cancer: Long-term Outcomes and a Comparison to Standard Dose-Escalated RT
    Weller, M. A.
    Kupelian, P. A.
    Reddy, C. A.
    Kotecha, R.
    Ciezki, J. P.
    Klein, E. A.
    Stephans, K. L.
    Tendulkar, R. D.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S152 - S153
  • [10] Patterns of relapse after concurrent temozolomide and dose-escalated intensity-modulated radiation therapy (IMRT) in newly diagnosed glioblastoma (GBM).
    Speers, Corey
    Junck, Larry
    Heth, Jason
    Cao, Yue
    Lawrence, Theodore Steven
    Tsien, Christina
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345